|
|
|
Volumn 9, Issue 2 SUPPL. 1, 1999, Pages 12-26
|
|
Combination of taxanes with radiation: Preclinical studies
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BETA TUBULIN;
DNA;
DOCETAXEL;
GENE PRODUCT;
OXYGEN;
PACLITAXEL;
PROTEIN BAX;
PROTEIN BCL 2;
PROTEIN P21;
PROTEIN P53;
TAXANE DERIVATIVE;
ANTINEOPLASTIC ACTIVITY;
APOPTOSIS;
CANCER RADIOTHERAPY;
CARCINOGENESIS;
CELL CYCLE;
CELL PROLIFERATION;
CYTOTOXICITY;
DRUG RESISTANCE;
GENE;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
MITOSIS;
NONHUMAN;
ONCOGENE;
PHOSPHORYLATION;
PRIORITY JOURNAL;
RADIATION DOSE;
RADIOSENSITIVITY;
RADIOSENSITIZATION;
REVIEW;
TUMOR;
ANIMALS;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
APOPTOSIS;
COMBINED MODALITY THERAPY;
DOSE-RESPONSE RELATIONSHIP, RADIATION;
MICE;
NEOPLASMS, EXPERIMENTAL;
PACLITAXEL;
RADIATION-SENSITIZING AGENTS;
RADIOTHERAPY DOSAGE;
TAXOIDS;
TUMOR CELLS, CULTURED;
|
|
EID: 0032900181
PISSN: 10534296
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (140)
|
|
References (83)
|
